TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 91 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q2 2017. The put-call ratio across all filers is 2.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $4,000 | – | 1,302 | +2356.6% | 0.00% | – |
| Q2 2018 | $0 | -100.0% | 53 | -84.5% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 342 | +71.0% | 0.00% | – |
| Q4 2017 | $1,000 | -97.0% | 200 | -95.8% | 0.00% | – |
| Q3 2017 | $33,000 | +1550.0% | 4,807 | +1289.3% | 0.00% | – |
| Q2 2017 | $2,000 | -85.7% | 346 | -76.8% | 0.00% | – |
| Q1 2017 | $14,000 | +27.3% | 1,494 | -45.7% | 0.00% | – |
| Q4 2016 | $11,000 | +1000.0% | 2,751 | +1577.4% | 0.00% | – |
| Q4 2015 | $1,000 | 0.0% | 164 | +51.9% | 0.00% | – |
| Q3 2015 | $1,000 | -98.3% | 108 | -91.2% | 0.00% | – |
| Q2 2015 | $58,000 | +2800.0% | 1,227 | +513.5% | 0.00% | – |
| Q1 2014 | $2,000 | -33.3% | 200 | -13.4% | 0.00% | – |
| Q3 2013 | $3,000 | – | 231 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 330,000 | $2,353,000 | 0.98% |
| EcoR1 Capital, LLC | 633,400 | $4,516,000 | 0.80% |
| DLD Asset Management, LP | 570,000 | $4,059,000 | 0.53% |
| Rhenman & Partners Asset Management AB | 300,000 | $2,139,000 | 0.31% |
| Eventide Asset Management | 600,000 | $4,278,000 | 0.27% |
| Tekla Capital Management LLC | 1,004,322 | $7,161,000 | 0.26% |
| Rock Springs Capital Management LP | 698,000 | $4,977,000 | 0.25% |
| DLD Asset Management, LP | 230,000 | $1,640,000 | 0.21% |
| Worth Venture Partners, LLC | 29,325 | $209,000 | 0.18% |
| Crestline Management, LP | 161,403 | $1,151,000 | 0.15% |